Skip to main content

Together we are beating cancer

Donate now

Drug discovery and development

Showing 12 out of 73 results

Scientists have shown that a drug combination slows cancer cell growth in a type of non-small cell lung cancer when tested in the lab. Scientists have shown that a drug combination slows cancer cell growth in a type of non-small cell lung cancer when tested in the lab.

by Cancer Research UK | News | 24 August 2016

24 August 2016

Cancer Research UK scientists have designed a computer model that applies techniques used to analyse social networks to identify new ways of treating cancer. Cancer Research UK scientists have designed a computer model that applies techniques used to analyse social networks to identify new ways of treating cancer.

by Cancer Research UK | News | 23 December 2015

23 December 2015

Scientists have shed more light on a vital cluster of proteins that helps cells – including cancer cells – to move around the body Scientists have shed more light on a vital cluster of proteins that helps cells – including cancer cells – to move around the body

by Cancer Research UK | News | 23 December 2015

23 December 2015

Cancer Research UK’s Drug Discovery Committee has awarded the Northern Institute of Cancer Research £5M to bring more cancer drugs to clinic trials. Cancer Research UK’s Drug Discovery Committee has awarded the Northern Institute of Cancer Research £5M to bring more cancer drugs to clinic trials.

by Cancer Research UK | News | 7 August 2015

7 August 2015

Cancer Research UK, Cancer Research Technology (CRT) and Monopar Therapeutics LLC will take forward an antibody treatment HuATN-658 into clinical trials. Cancer Research UK, Cancer Research Technology (CRT) and Monopar Therapeutics LLC will take forward an antibody treatment HuATN-658 into clinical trials.

by Cancer Research Technology (CRT) | News | 9 July 2015

9 July 2015

Cancer Research UK is to increase investment by nearly 50 per cent over the next five years in its Centre for Drug Development. Cancer Research UK is to increase investment by nearly 50 per cent over the next five years in its Centre for Drug Development.

by Cancer Research UK | News | 29 September 2014

29 September 2014